Mariner
BPMC

Mariner’s Blueprint Medicines BPMC Stock Holding History

Mariner’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,605
Closed -$975K – 3576
2025
Q2 		$975K Buy
7,605
+123
+2% +$12.8K ﹤0.01% 1806
2025
Q1 		$662K Buy
7,482
+4,279
+134% +$417K ﹤0.01% 1972
2024
Q4 		$279K Buy
3,203
+43
+1% +$3.94K ﹤0.01% 2696
2024
Q3 		$292K Buy
3,160
+193
+7% +$19.2K ﹤0.01% 2590
2024
Q2 		$320K Sell
2,967
-75
-2% -$7.51K ﹤0.01% 2397
2024
Q1 		$289K Buy
3,042
+97
+3% +$8.32K ﹤0.01% 2467
2023
Q4 		$272K Buy
+2,945
New +$191K ﹤0.01% 2435

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mariner's BPMC Position: Q3 2025 in Review

Mariner sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 7,605 shares — an estimated $975K sold.

Mariner first reported a position in BPMC in Q4 2023 and held it in 7 quarters. The position peaked at $975K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Mariner reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Mariner sold 7,605 Blueprint Medicines shares in Q3 2025, an estimated $975K.
  • Mariner first reported a position in Blueprint Medicines in Q4 2023 and held it in 7 quarters.
  • Mariner's Blueprint Medicines position peaked at $975K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.